Axa S.A. Axonics, Inc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $88.4 Million - $108 Million	-1,559,548 Reduced 99.37%	9,918 $684,000
Q4 2023 Jul 16, 2024	BUY	$49.38 - $63.75 $77 Million - $99.4 Million	1,559,548 Added 15724.42%	1,569,466 $97.7 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $7.83 Million - $10.1 Million	-158,645 Reduced 9.18%	1,569,466 $97.7 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $3.27 Million - $4.21 Million	67,305 Added 4.05%	1,728,111 $97 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $548,621 - $688,320	-11,432 Reduced 0.68%	1,660,806 $83.8 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $4.67 Million - $5.98 Million	88,852 Added 5.61%	1,672,238 $91.2 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $2.41 Million - $3.1 Million	40,441 Added 2.62%	1,583,386 $99 Million
Q3 2022 Feb 14, 2023	SELL	$57.96 - $78.12 $13.8 Million - $18.6 Million	-237,958 Reduced 13.36%	1,542,945 $109 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $13.8 Million - $18.6 Million	-237,958 Reduced 13.36%	1,542,945 $109 Million
Q2 2022 Feb 14, 2023	SELL	$39.5 - $64.42 $2.04 Million - $3.33 Million	-51,709 Reduced 2.82%	1,780,903 $101 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $2.04 Million - $3.33 Million	-51,709 Reduced 2.82%	1,780,903 $101 Million
Q1 2022 Feb 14, 2023	BUY	$43.74 - $62.76 $12.7 Million - $18.2 Million	289,667 Added 18.77%	1,832,612 $115 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $52,094 - $74,747	1,191 Added 0.07%	1,832,612 $115 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $15.1 Million - $22.2 Million	302,190 Added 19.76%	1,831,421 $103 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $10.1 Million - $13.4 Million	-170,449 Reduced 10.03%	1,529,231 $99.5 Million
Q2 2021 Aug 13, 2021	BUY	$51.39 - $66.9 $9.01 Million - $11.7 Million	175,407 Added 11.51%	1,699,680 $108 Million
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $108,304 - $131,997	2,204 Added 0.14%	1,524,273 $91.3 Million
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $7.64 Million - $9.33 Million	181,162 Added 13.51%	1,522,069 $76 Million
Q3 2020 Nov 13, 2020	SELL	$35.33 - $51.04 $4.97 Million - $7.18 Million	-140,702 Reduced 9.5%	1,340,907 $68.4 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $12.8 Million - $22.2 Million	557,209 Added 60.28%	1,481,609 $52 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $15.2 Million - $34.9 Million	924,400 New	924,400 $23.5 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account